Please assess the completion status of the following clinical trial:

Trial Title: Safety and Effectiveness of Agilus (Hyaluronic Acid) for Ankle Osteoarthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years or older~* Chronic, unilateral ankle pain(i.e., in only one ankle) for at least 6 months~* Diagnosis of ankle OA confirmed by radiographs (X-ray)and clinical exam~* Are normally active, without aid of mobility devices(such as crutch, walker or cane)~Exclusion Criteria:~* Have used oral steroids within 30 days (inhaled or topical steroids are acceptable)~* Have received intra-articular injections of hyaluronic acid in any joint in the last 9 months~* Have received steroid injections in any joint in last 3 months~* Have had previous surgery or arthroscopy on the affected ankle in the last 12 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 95 Years
- Healthy Volunteers: f

Study Arms:
- Active (Type: ACTIVE_COMPARATOR): Agilus (Hyaluronic Acid)
- Control (Type: PLACEBO_COMPARATOR): Normal Saline

Based on this trial design, predict the completion outcome and termination type (if applicable).